Life Biosciences is a developer of drugs designed to promote longevity and find treatments for age-related diseases.
Life Biosciences has raised $80.0M in total funding. The most recent round was Series D. The last funding was announced in April 2026.
Life Biosciences's investors include Longevitytech.fund, LeFrak, Alpha Wave Ventures, Apple Core Holdings, Abundance Partners.
Life Biosciences is headquartered in Boston, United States.
Life Biosciences is a developer of drugs designed to promote longevity and find treatments for age-related diseases.
Life Biosciences is at the Series D stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Life Biosciences — Funding & Investors." VCBacked, April 8, 2026, https://www.vcbacked.co/company/life-biosciences. Accessed July 31, 2026.
VCBacked. (2026). Life Biosciences — Funding & Investors. Retrieved July 31, 2026, from https://www.vcbacked.co/company/life-biosciences
{{cite web |title=Life Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/life-biosciences |website=VCBacked |access-date=July 31, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated